Article Details

ImmunAbs Inc. Announces US FDA Approval for a Phase 1 Clinical Trial | Antibodies

Retrieved on: 2022-08-04 14:37:45

Tags for this article:

Click the tags to see associated articles and topics

ImmunAbs Inc. Announces US FDA Approval for a Phase 1 Clinical Trial | Antibodies. View article details on hiswai:

Excerpt

ImmunAbs is developing IM-101, a monoclonal antibody targeting complements that play essential roles in the immune system but, ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up